found that sCD36 was markedly elevated in T2DM patients compared with both lean (5‐fold) and obese (2‐ to 3‐fold) control subjects, and sCD36 was highly related to risk factors of accelerated atherosclerosis in T2DM such as insulin‐stimulated glucose disposal, fasting plasma glucose, fasting insulin, and body mass index (BMI). The gene discussed is INS; the disease is atherosclerosis.